Executive Order Advances Medical Marijuana and CBD Research
Impact Score: 3.2
Timeline: Expeditious implementation; no specific deadlines provided
Summary: The executive order directs agencies to enhance medical marijuana and hemp-derived CBD research, addressing federal neglect and improving prescribing practices and patient safety. It mandates rescheduling marijuana from Schedule I to III to reflect medical use and lower abuse potential. Agencies including FDA, HHS, NIH, CMS, DEA, and DOJ are tasked with updating research protocols, regulatory definitions, and safety standards. Vanderbilt University programs such as Medical School, Nursing, Law, and Peabody College stand to benefit from increased research funding, curriculum updates, and interdisciplinary collaboration.
Key Actions: Vanderbilt Medical School to collaborate on research; expand Addiction Research initiatives; Law School to analyze evolving regulations; School of Nursing to integrate education on medical marijuana and CBD; Office of Federal Relations to engage with policymakers for compliance and advocacy.
View Full Report
